Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells

ConditionPregnant Women

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorUniversity Hospital, Montpellier

About this trial

Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.

Eligibility criteria

Qualifiers

Pregnant woman

Singleton pregnancy

Pregnancy between 7 and 16 weeks of amenorrhea (WA)

Woman ≥ 18 years

Disqualifiers

None

Trial design

Treatments tested in this trial

Inclusion (Visit 1 - Week 7-16)
Second semester of pregnancy (Visit 2 - Week 20-24)
Third semester of pregnancy (Visit 3- Week 34)

Treatment groups

25 Participants

are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Montpellier

Lead sponsor

Source ClinicalTrials.gov